WCLC 2022 Conference Coverage

 

Videos
01:43

WCLC 2022 Conference Coverage

Lecture Summary - EGFR Testing in Practices, Treatment Choice, and Clinical Outcomes in Advanced NSCLC in a Real-World Setting

FEATURING Janakiraman Subramanian
  • 20 views
  • October 11, 2022
09:45

WCLC 2022 Conference Coverage

EGFR Testing in Practices, Treatment Choice, and Clinical Outcomes in Advanced NSCLC in a Real-World Setting

FEATURING Janakiraman Subramanian
  • 336 views
  • October 11, 2022
16:55

WCLC 2022 Conference Coverage

WCLC 2022: Early Stage NSCLC Highlights

FEATURING Riyaz Shah
  • 82 views
  • October 11, 2022
40

WCLC 2022 Conference Coverage

Lecture Summary - Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant NSCLC

FEATURING Byoung Chul Cho
  • 9 views
  • September 27, 2022
08:49

WCLC 2022 Conference Coverage

Amivantamab and Lazertinib in Treatment-Naïve EGFRm NSCLC

FEATURING Byoung Chul Cho
  • 49 views
  • September 27, 2022
53

WCLC 2022 Conference Coverage

Lecture Summary - Sotorasib in Combination With RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors

FEATURING Gerald Falchook
  • 16 views
  • September 16, 2022
07:16

WCLC 2022 Conference Coverage

Sotorasib in Combination With RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors

FEATURING Gerald Falchook
  • 141 views
  • September 16, 2022
45

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: Does Quitting Smoking After a Diagnosis of Lung Cancer Improve Survival?

FEATURING Jacek Jassem
  • 135 views
  • September 16, 2022
  • 2
09:43

WCLC 2022 Conference Coverage

WCLC 2022: Does Quitting Smoking After a Diagnosis of Lung Cancer Improve Survival?

FEATURING Jacek Jassem
  • 736 views
  • September 16, 2022
  • 7
13:46

WCLC 2022 Conference Coverage

Predictive Biomarkers for Immunotherapy in Lung Cancer

FEATURING Fred Hirsch
  • 530 views
  • September 15, 2022
  • 4
06:00

WCLC 2022 Conference Coverage

WCLC 2022 on the Phase 2 Study of Pevonedistat in Combination With Carboplatin & Paclitaxel in Advanced NSCLC Previously Treated With IO

FEATURING Ralph Millett
  • 6 views
  • September 14, 2022
39

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Use of Medical Cannabis Concomitantly With Immune Checkpoint Inhibitors Among NSCLC Pts: A Sigh of Relief?

FEATURING Barliz Waissengrin
  • 84 views
  • September 7, 2022
  • 2
04:19

WCLC 2022 Conference Coverage

WCLC 2022 on the Use of Medical Cannabis Concomitantly With Immune Checkpoint Inhibitors Among NSCLC Pts: A Sigh of Relief?

FEATURING Barliz Waissengrin
  • 7 views
  • September 7, 2022
11:15

WCLC 2022 Conference Coverage

WCLC 2022 on the ADAURA2 Phase III Study: Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFRm NSCLC

FEATURING Toon van der Gronde
  • 55 views
  • September 7, 2022
40

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Malignant Pleural Mesothelioma

FEATURING Marko Jakopovic
  • 1 view
  • September 7, 2022
16:56

WCLC 2022 Conference Coverage

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Malignant Pleural Mesothelioma

FEATURING Marko Jakopovic
  • 29 views
  • September 7, 2022
44

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Role of Nanoparticle Polymeric Micellar Paclitaxel in Reducing Toxicity and Enhancing Efficacy in NSCLC

FEATURING Baohui Han
  • 5 views
  • September 7, 2022
08:25

WCLC 2022 Conference Coverage

WCLC 2022 on the Role of Nanoparticle Polymeric Micellar Paclitaxel in Reducing Toxicity and Enhancing Efficacy in NSCLC

FEATURING Baohui Han
  • 11 views
  • September 7, 2022
39

WCLC 2022 Conference Coverage

Lecture Summary - A Phase II Study of Metformin With Pemetrexed/Carboplatin in Metastatic Non-Squamous NSCLC

FEATURING Saurav Verma
  • 4 views
  • September 7, 2022
08:09

WCLC 2022 Conference Coverage

A Phase II Study of Metformin With Pemetrexed/Carboplatin in Metastatic Non-Squamous NSCLC

FEATURING Saurav Verma
  • 9 views
  • September 7, 2022
01:07

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes With PD-L1 Blockade to Reverse Type-2 Mediated Immunosuppression

FEATURING Thomas Marron
  • 4 views
  • September 6, 2022
11:14

WCLC 2022 Conference Coverage

WCLC 2022 on Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes With PD-L1 Blockade to Reverse Type-2 Mediated Immunosuppression

FEATURING Thomas Marron
  • 44 views
  • September 6, 2022
09:56

WCLC 2022 Conference Coverage

WCLC 2022 Efficacy of 1L Immune Checkpoint Inhibitors in Advanced NSCLC Harboring KRAS, MET, FGFR, RET, BRAF, and HER2 Alterations

FEATURING Yuji Uehara
  • 302 views
  • August 29, 2022
41

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Molecular Diagnostics in Clinical Practice for NSCLC

FEATURING Umberto Malapelle
  • 8 views
  • August 29, 2022
04:50

WCLC 2022 Conference Coverage

WCLC 2022 on Molecular Diagnostics in Clinical Practice for NSCLC

FEATURING Umberto Malapelle
  • 203 views
  • August 29, 2022
05:34

WCLC 2022 Conference Coverage

WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT in Unresectable Locally Advanced NSCLC

FEATURING Motoko Tachihara
  • 63 views
  • August 29, 2022
02:26

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: A Multi-Omics Approach for Delineating Tissue Signatures of Immunotherapy Response in Lung Cancer

FEATURING Arutha Kulasinghe
  • 2 views
  • August 29, 2022
12:07

WCLC 2022 Conference Coverage

WCLC 2022: A Multi-Omics Approach for Delineating Tissue Signatures of Immunotherapy Response in Lung Cancer

FEATURING Arutha Kulasinghe
  • 35 views
  • August 29, 2022
56

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Socio-Economic Inequalities in NSCLC Treatment During the Era of Tumor Biomarker Guided Therapy: A Population-Based Study

FEATURING Ruth Norris
  • 76 views
  • August 29, 2022
  • 1
12:35

WCLC 2022 Conference Coverage

WCLC 2022 on Socio-Economic Inequalities in NSCLC Treatment During the Era of Tumor Biomarker Guided Therapy: A Population-Based Study

FEATURING Ruth Norris
  • 32 views
  • August 29, 2022
16:09

WCLC 2022 Conference Coverage

WCLC 2022 on Biomarker Identification of Hard-to-Treat NSCLC Patients: Shining a Spotlight on Unmet Need

FEATURING Niels Reinmuth
  • 122 views
  • August 25, 2022
50

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: All You Need to Know About KRAS in NSCLC

FEATURING Odd Terje Brustugun
  • 2 views
  • August 24, 2022
16:26

Odd Terje Brustugun

All You Need to Know About KRAS in NSCLC

  • 317 views
  • August 24, 2022
  • 2
05:52

WCLC 2022 Conference Coverage

WCLC 2022 on the Progression Pattern, Resistance Mechanism, and Subsequent Therapy for ALK+ NSCLC in the Era of 2nd Gen ALK-TKIs

FEATURING Zihua Zou
  • 173 views
  • August 23, 2022
  • 2
12:55

WCLC 2022 Conference Coverage

WCLC 2022 on the Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III NSCLC in the Durvalumab Era

FEATURING Neal McCall
  • 129 views
  • August 23, 2022
49

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Impact of Precision Medicine Methods on 1L Therapies in mNSCLC

FEATURING Chetan Vakkalagadda
  • 6 views
  • August 23, 2022
07:06

WCLC 2022 Conference Coverage

WCLC 2022 Impact of Precision Medicine Methods on 1L Therapies in mNSCLC

FEATURING Chetan Vakkalagadda
  • 81 views
  • August 23, 2022
01:10

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Frequency and Detectability of Uncommon EGFR Mutations in NSCLC

FEATURING Hazel O'Sullivan
  • 2 views
  • August 23, 2022
04:06

WCLC 2022 Conference Coverage

WCLC 2022 on Frequency and Detectability of Uncommon EGFR Mutations in NSCLC

FEATURING Hazel O'Sullivan
  • 73 views
  • August 23, 2022
51

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Phase II Study of ctDNA Directed Consolidation Durvalumab After Induction and Concurrent Durvalumab With SABR for Stage I NSCLC

FEATURING Islam Mohamed
  • 24 views
  • August 23, 2022
  • 1
10:44

WCLC 2022 Conference Coverage

WCLC 2022 Phase II Study of ctDNA Directed Consolidation Durvalumab After Induction and Concurrent Durvalumab With SABR for Stage I NSCLC

FEATURING Islam Mohamed
  • 9 views
  • August 23, 2022
01:22

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumor Treating Fields (150 kHz) + Pembro for Advanced/Metastatic NSCLC

FEATURING Rupesh Kotecha
  • 6 views
  • August 23, 2022
09:13

WCLC 2022 Conference Coverage

WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumor Treating Fields (150 kHz) + Pembro for Advanced/Metastatic NSCLC

FEATURING Rupesh Kotecha
  • 59 views
  • August 23, 2022
  • 2
01:43

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Modifiable Biomarkers of Response to Immune Checkpoint Inhibitor Treatment in NSCLC

FEATURING Daniel Spakowicz
  • 1 view
  • August 23, 2022
10:17

WCLC 2022 Conference Coverage

WCLC 2022 on Modifiable Biomarkers of Response to Immune Checkpoint Inhibitor Treatment in NSCLC

FEATURING Daniel Spakowicz
  • 151 views
  • August 23, 2022
  • 1
01:01

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Impact of PET/CT-Derived Metabolic Parameters on Outcomes in ES-SCLC

FEATURING Giuseppe Lamberti
  • 65 views
  • August 23, 2022
  • 1
04:28

WCLC 2022 Conference Coverage

WCLC 2022 Impact of PET/CT-Derived Metabolic Parameters on Outcomes in ES-SCLC

FEATURING Giuseppe Lamberti
  • 96 views
  • August 23, 2022
01:34

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Update From the European EXOTIC Registry on Exon-20 EGFR Mutations in NSCLC

FEATURING Giannis Mountzios
  • 3 views
  • August 18, 2022
13:13

WCLC 2022 Conference Coverage

WCLC 2022 Update From the European EXOTIC Registry on Exon-20 EGFR Mutations in NSCLC

FEATURING Giannis Mountzios
  • 21 views
  • August 18, 2022
  • 1
46

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: BBT-176, a 4th Gen EGFR TKI, for Progressed NSCLC After EGFR TKI Therapy: PK, Safety, and Preliminary Efficacy Results

FEATURING Sun Min Lim
  • 9 views
  • August 18, 2022
06:23

WCLC 2022 Conference Coverage

WCLC 2022: BBT-176, a 4th Gen EGFR TKI, for Progressed NSCLC After EGFR TKI Therapy: PK, Safety, and Preliminary Efficacy Results

FEATURING Sun Min Lim
  • 91 views
  • August 18, 2022
48

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ Disease

FEATURING Jay Lee
  • 8 views
  • August 18, 2022
07:38

WCLC 2022 Conference Coverage

WCLC 2022 on the Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ Disease

FEATURING Jay Lee
  • 71 views
  • August 18, 2022
12:41

WCLC 2022 Conference Coverage

WCLC 2022 on Optimum Surgical Staging and Tissue Acquisition for Adjuvant Immunotherapy and Targeted Treatments in NSCLC

FEATURING Paula Ugalde Figueroa
  • 55 views
  • August 18, 2022
  • 1
34

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Molecular Profiling and Biomarkers in Lung NET

FEATURING Alexandra Sexton-Oates
  • 1 view
  • August 18, 2022
11:51

WCLC 2022 Conference Coverage

WCLC 2022 Molecular Profiling and Biomarkers in Lung NET

FEATURING Alexandra Sexton-Oates
  • 87 views
  • August 18, 2022
  • 1
01:06

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: Adding Alectinib Rescues Progression on Osimertinib Due to Acquired ALK p.R1275Q Variant in EGFR p.L858R-Mutated NSCLC

FEATURING Edyta Urbanska
  • 3 views
  • August 18, 2022
08:52

WCLC 2022 Conference Coverage

WCLC 2022: Adding Alectinib Rescues Progression on Osimertinib Due to Acquired ALK p.R1275Q Variant in EGFR p.L858R-Mutated NSCLC

FEATURING Edyta Urbanska
  • 36 views
  • August 18, 2022
02:39

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Role of Completion Lobectomy Following Sublobar Resection in Patients With T1 NSCLC

FEATURING Akif Turna
  • 6 views
  • August 18, 2022
07:56

WCLC 2022 Conference Coverage

WCLC 2022 on the Role of Completion Lobectomy Following Sublobar Resection in Patients With T1 NSCLC

FEATURING Akif Turna
  • 7 views
  • August 18, 2022
01:32

WCLC 2022 Conference Coverage

Lecture Summary - WCLC on Prevalence and Outcomes of EGFR Exon 20 Insertion Mutation in NSCLC: Princess Margaret Cancer Center Experience

FEATURING Abhenil Mittal
  • 3 views
  • August 18, 2022
07:31

WCLC 2022 Conference Coverage

WCLC on Prevalence and Outcomes of EGFR Exon 20 Insertion Mutation in NSCLC: Princess Margaret Cancer Center Experience

FEATURING Abhenil Mittal
  • 78 views
  • August 18, 2022
40

WCLC 2022 Conference Coverage

Lacture Summary - WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + Lenvatinib in 2L/3L Malignant Pleural Mesothelioma Patients

FEATURING Li-Anne Huaqing Douma
  • 4 views
  • August 18, 2022
07:16

WCLC 2022 Conference Coverage

WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + Lenvatinib in 2L/3L Malignant Pleural Mesothelioma Patients

FEATURING Li-Anne Huaqing Douma
  • 15 views
  • August 18, 2022
40

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Differential Diagnosis of Pneumonitis in mNSCLC Pts Receiving Immunotherapy With Radiomics

FEATURING Alberto Traverso
  • 10 views
  • August 18, 2022
13:19

WCLC 2022 Conference Coverage

WCLC 2022 on Differential Diagnosis of Pneumonitis in mNSCLC Pts Receiving Immunotherapy With Radiomics

FEATURING Alberto Traverso
  • 62 views
  • August 18, 2022
  • 1
35

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherapy in Stage IV LCNEC of the Lung

FEATURING Lingbin Meng
  • 1 view
  • August 18, 2022
04:11

WCLC 2022 Conference Coverage

WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherapy in Stage IV LCNEC of the Lung

FEATURING Lingbin Meng
  • 77 views
  • August 18, 2022
  • 1
52

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: Could MRD Change Our Clinical Practice? North American Perspective

FEATURING Aadel Chaudhuri
  • 2 views
  • August 18, 2022
17:11

WCLC 2022 Conference Coverage

WCLC 2022: Could MRD Change Our Clinical Practice? North American Perspective

FEATURING Aadel Chaudhuri
  • 179 views
  • August 18, 2022
  • 2
07:18

WCLC 2022 Conference Coverage

WCLC 2022 on the NADIM II Trial: Pre-Treatment ctDNA Levels Significantly Predict OS & PFS in Locally Advanced & Potentially Resectable NSCLC

FEATURING Atocha Romero
  • 85 views
  • August 18, 2022
  • 1
12:46

WCLC 2022 Conference Coverage

WCLC 2022 Immunotherapy in Oncogene-Addicted NSCLC

FEATURING Francesco Passiglia
  • 93 views
  • August 18, 2022
06:45

WCLC 2022 Conference Coverage

WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Combination With Osimertinib in EGFRm and MET Overexpressed NSCLC

FEATURING Qing Zhou
  • 157 views
  • August 18, 2022
56

WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on MRD Status Affecting Decisions on Adjuvant Therapy in NSCLC

FEATURING Federico Cappuzzo
  • 7 views
  • August 18, 2022
11:20

WCLC 2022 Conference Coverage

WCLC 2022 on MRD Status Affecting Decisions on Adjuvant Therapy in NSCLC

FEATURING Federico Cappuzzo
  • 85 views
  • August 18, 2022
09:33

WCLC 2022 Conference Coverage

WCLC 2022 Prognostic Factors in Curative Intent Stage I Lung Adenocarcinoma: Hospital's Cancer Registry Based Analysis

FEATURING Vinícius Silva
  • 143 views
  • August 8, 2022
  • 3
05:50

WCLC 2022 Conference Coverage

WCLC 2022 on Early Detection Plus Timely Surgery Remains the Standard Despite Advances in Immunotherapy

FEATURING Emanuela Taioli
  • 65 views
  • August 1, 2022
  • 1